Atlas Trials

Biomea Fusion Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Biomea Fusion Inc.

RecordFirmDate
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy (NCT07502508)Biomea Fusion Inc.2026-04-30
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets (NCT07502495)Biomea Fusion Inc.2026-03-27
Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants (NCT07223216)Biomea Fusion Inc.2025-10-23
Food Effect Study in Healthy Volunteers (NCT07254286)Biomea Fusion Inc.2025-09-11
Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus (NCT06152042)Biomea Fusion Inc.2023-12-28
A Phase 1 Study of BMF-500 in Adults With Acute Leukemia (NCT05918692)Biomea Fusion Inc.2023-07-26
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer (NCT05631574)Biomea Fusion Inc.2023-01-12
Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D) (NCT05731544)Biomea Fusion Inc.2022-08-17
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL (NCT05153330)Biomea Fusion Inc.2022-01-24

Track Biomea Fusion Inc. automatically

Every clearance here is in the API, with alerts when new ones post.